Purisys has a history of proactively partnering with regulators to maintain the highest level of trust and to anticipate changes in the regulations, standards, and public expectations.

FDA Inspections

• 2005 – Zero 483 findings
• 2006 – Zero 483 findings
• 2009 – Zero 483 findings
• 2011 – Zero 483 findings
• 2014 – Zero 483 findings
• 2017 – Zero 483 findings

Additional Health Authority Inspections

• 2013 – COFEPRIS (Mexico)
• 2012 – Korea FDA

DEA Inspections
Strong proactive relationship with Atlanta and Washington offices. No findings in last inspections:

• 2017 – 5 visits by DEA
• 2018 – 3 visits by DEA
• 2019 – 3 visits by DEA
• 2020 – 2 visits by DEA (license approval)